207 related articles for article (PubMed ID: 25039779)
1. Accessing targeted nanoparticles to the brain: the vascular route.
Burkhart A; Azizi M; Thomsen MS; Thomsen LB; Moos T
Curr Med Chem; 2014; 21(36):4092-9. PubMed ID: 25039779
[TBL] [Abstract][Full Text] [Related]
2. Nanoparticle-derived non-viral genetic transfection at the blood-brain barrier to enable neuronal growth factor delivery by secretion from brain endothelium.
Thomsen LB; Larsen AB; Lichota J; Moos T
Curr Med Chem; 2011; 18(22):3330-4. PubMed ID: 21728969
[TBL] [Abstract][Full Text] [Related]
3. Targeted transport of biotherapeutics at the blood-brain barrier.
Moos T; Thomsen MS; Burkhart A; Hede E; Laczek B
Expert Opin Drug Deliv; 2023; 20(12):1823-1838. PubMed ID: 38059358
[TBL] [Abstract][Full Text] [Related]
4. Modulating the antibody density changes the uptake and transport at the blood-brain barrier of both transferrin receptor-targeted gold nanoparticles and liposomal cargo.
Johnsen KB; Bak M; Melander F; Thomsen MS; Burkhart A; Kempen PJ; Andresen TL; Moos T
J Control Release; 2019 Feb; 295():237-249. PubMed ID: 30633947
[TBL] [Abstract][Full Text] [Related]
5. Advances in nanocarriers enabled brain targeted drug delivery across blood brain barrier.
Sharma G; Sharma AR; Lee SS; Bhattacharya M; Nam JS; Chakraborty C
Int J Pharm; 2019 Mar; 559():360-372. PubMed ID: 30721725
[TBL] [Abstract][Full Text] [Related]
6. Targeting nanoparticles to the brain by exploiting the blood-brain barrier impermeability to selectively label the brain endothelium.
Gonzalez-Carter D; Liu X; Tockary TA; Dirisala A; Toh K; Anraku Y; Kataoka K
Proc Natl Acad Sci U S A; 2020 Aug; 117(32):19141-19150. PubMed ID: 32703811
[TBL] [Abstract][Full Text] [Related]
7. Revisiting nanoparticle technology for blood-brain barrier transport: Unfolding at the endothelial gate improves the fate of transferrin receptor-targeted liposomes.
Johnsen KB; Moos T
J Control Release; 2016 Jan; 222():32-46. PubMed ID: 26658072
[TBL] [Abstract][Full Text] [Related]
8. Targeted drug delivery to the brain using magnetic nanoparticles.
Thomsen LB; Thomsen MS; Moos T
Ther Deliv; 2015; 6(10):1145-55. PubMed ID: 26446407
[TBL] [Abstract][Full Text] [Related]
9. Recent progress of drug nanoformulations targeting to brain.
Khan AR; Yang X; Fu M; Zhai G
J Control Release; 2018 Dec; 291():37-64. PubMed ID: 30308256
[TBL] [Abstract][Full Text] [Related]
10. Cellular uptake of PLGA nanoparticles targeted with anti-amyloid and anti-transferrin receptor antibodies for Alzheimer's disease treatment.
Loureiro JA; Gomes B; Fricker G; Coelho MAN; Rocha S; Pereira MC
Colloids Surf B Biointerfaces; 2016 Sep; 145():8-13. PubMed ID: 27131092
[TBL] [Abstract][Full Text] [Related]
11. Comparison of polypeptides that bind the transferrin receptor for targeting gold nanocarriers.
McQuaid C; Halsey A; Dubois M; Romero I; Male D
PLoS One; 2021; 16(6):e0252341. PubMed ID: 34086733
[TBL] [Abstract][Full Text] [Related]
12. Increased brain uptake of targeted nanoparticles by adding an acid-cleavable linkage between transferrin and the nanoparticle core.
Clark AJ; Davis ME
Proc Natl Acad Sci U S A; 2015 Oct; 112(40):12486-91. PubMed ID: 26392563
[TBL] [Abstract][Full Text] [Related]
13. Transferrin receptor expression and role in transendothelial transport of transferrin in cultured brain endothelial monolayers.
Hersom M; Helms HC; Pretzer N; Goldeman C; Jensen AI; Severin G; Nielsen MS; Holm R; Brodin B
Mol Cell Neurosci; 2016 Oct; 76():59-67. PubMed ID: 27567687
[TBL] [Abstract][Full Text] [Related]
14. Niosomes decorated with dual ligands targeting brain endothelial transporters increase cargo penetration across the blood-brain barrier.
Mészáros M; Porkoláb G; Kiss L; Pilbat AM; Kóta Z; Kupihár Z; Kéri A; Galbács G; Siklós L; Tóth A; Fülöp L; Csete M; Sipos Á; Hülper P; Sipos P; Páli T; Rákhely G; Szabó-Révész P; Deli MA; Veszelka S
Eur J Pharm Sci; 2018 Oct; 123():228-240. PubMed ID: 30031862
[TBL] [Abstract][Full Text] [Related]
15. HI 6 human serum albumin nanoparticles--development and transport over an in vitro blood-brain barrier model.
Dadparvar M; Wagner S; Wien S; Kufleitner J; Worek F; von Briesen H; Kreuter J
Toxicol Lett; 2011 Sep; 206(1):60-6. PubMed ID: 21726608
[TBL] [Abstract][Full Text] [Related]
16. Nanoparticles for Targeted Brain Drug Delivery: What Do We Know?
Pinheiro RGR; Coutinho AJ; Pinheiro M; Neves AR
Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34769082
[TBL] [Abstract][Full Text] [Related]
17. Two peptides targeting endothelial receptors are internalized into murine brain endothelial cells.
Hudecz D; Sigurdardóttir SB; Christensen SC; Hempel C; Urquhart AJ; Andresen TL; Nielsen MS
PLoS One; 2021; 16(4):e0249686. PubMed ID: 33798235
[TBL] [Abstract][Full Text] [Related]
18. Antibody affinity and valency impact brain uptake of transferrin receptor-targeted gold nanoparticles.
Johnsen KB; Bak M; Kempen PJ; Melander F; Burkhart A; Thomsen MS; Nielsen MS; Moos T; Andresen TL
Theranostics; 2018; 8(12):3416-3436. PubMed ID: 29930740
[No Abstract] [Full Text] [Related]
19. Noninvasive nanoparticle strategies for brain tumor targeting.
Sun C; Ding Y; Zhou L; Shi D; Sun L; Webster TJ; Shen Y
Nanomedicine; 2017 Nov; 13(8):2605-2621. PubMed ID: 28756093
[TBL] [Abstract][Full Text] [Related]
20. The role of non-endothelial cells on the penetration of nanoparticles through the blood brain barrier.
Moura RP; Almeida A; Sarmento B
Prog Neurobiol; 2017 Dec; 159():39-49. PubMed ID: 28899762
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
